American Shared Hospital Services (AMS) Financial Statements (2025 and earlier)
Company Profile
Business Address |
601 MONTGOMERY STREET SAN FRANCISCO, CA 94111 |
State of Incorp. | CA |
Fiscal Year End | December 31 |
Industry (SIC) | 8071 - Medical Laboratories (benchmarking) |
More info | Complete Financial Analysis Financial Benchmarking |
Balance Sheet (Statement of Financial Position) ($ in thousands)
9/30/2024 MRQ | 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | 12/31/2018 | |||
---|---|---|---|---|---|---|---|---|---|
ASSETS | |||||||||
Current Assets | |||||||||
Cash, cash equivalents, and short-term investments | 13,690 | 12,335 | 8,145 | 3,961 | 1,429 | 1,442 | |||
Cash and cash equivalent | 13,690 | 12,335 | 8,145 | 3,961 | 1,429 | 1,442 | |||
Restricted cash and investments | 118 | 118 | 118 | 364 | 350 | 350 | |||
Receivables | 4,847 | 4,128 | 4,824 | 4,575 | 7,063 | 6,878 | |||
Other undisclosed current assets | 1,801 | 2,142 | 2,000 | 1,950 | 1,900 | 1,276 | |||
Total current assets: | 20,456 | 18,723 | 15,087 | 10,850 | 10,742 | 9,946 | |||
Noncurrent Assets | |||||||||
Operating lease, right-of-use asset | 57 | 317 | 654 | 886 | ✕ | ||||
Property, plant and equipment | (55,364) | (50,751) | (45,678) | 19 | 41,480 | 46,694 | |||
Intangible assets, net (including goodwill) | 1,343 | 1,343 | 1,343 | 1,343 | |||||
Goodwill | 1,265 | 1,265 | 1,265 | 1,265 | |||||
Intangible assets, net (excluding goodwill) | 78 | 78 | 78 | 78 | |||||
Other noncurrent assets | 443 | 87 | 73 | 137 | 455 | 862 | |||
Other undisclosed noncurrent assets | 81,227 | 74,237 | 73,951 | 30,418 | 1,106 | ||||
Total noncurrent assets: | 27,706 | 25,233 | 30,343 | 32,803 | 43,041 | 47,556 | |||
TOTAL ASSETS: | 48,162 | 43,956 | 45,430 | 43,653 | 53,783 | 57,502 | |||
LIABILITIES AND EQUITY | |||||||||
Liabilities | |||||||||
Current Liabilities | |||||||||
Accounts payable and accrued liabilities | 2,298 | 2,509 | 3,588 | 3,506 | 2,225 | 1,971 | |||
Taxes payable | ✕ | ✕ | ✕ | 373 | 130 | ||||
Employee-related liabilities | ✕ | ✕ | ✕ | 423 | 405 | 234 | 207 | ||
Accounts payable | 315 | 230 | 746 | 683 | 557 | 435 | |||
Accrued liabilities | 1,983 | 2,279 | 2,419 | 2,045 | 1,304 | 1,329 | |||
Debt | 2,084 | 1,262 | 1,081 | 7,102 | 5,235 | 6,526 | |||
Asset retirement obligation | 250 | 757 | 1,270 | ||||||
Due to related parties | ✕ | ✕ | 497 | ||||||
Other undisclosed current liabilities | 6,147 | 907 | 465 | 502 | 754 | 977 | |||
Total current liabilities: | 10,779 | 5,175 | 5,891 | 12,380 | 8,214 | 9,474 | |||
Noncurrent Liabilities | |||||||||
Long-term debt and lease obligation | 11,041 | 12,205 | 14,682 | 6,995 | 10,131 | 13,640 | |||
Long-term debt, excluding current maturities | 11,041 | 12,205 | 14,323 | 3,440 | 1,954 | 3,332 | |||
Capital lease obligations | ✕ | ✕ | ✕ | ✕ | ✕ | 8,177 | 10,308 | ||
Finance lease, liability | 2,974 | ✕ | |||||||
Liabilities, other than long-term debt | 63 | 951 | 618 | 628 | 2,800 | 2,958 | |||
Deferred revenue | 70 | 140 | 210 | ✕ | |||||
Contract with customer, liability | ✕ | ✕ | ✕ | ✕ | ✕ | 286 | |||
Deferred tax liabilities, net | ✕ | ✕ | ✕ | ✕ | ✕ | 2,514 | 2,958 | ||
Deferred income tax liabilities | 63 | 822 | 478 | 418 | ✕ | ||||
Operating lease, liability | 59 | 359 | 581 | ✕ | |||||
Other undisclosed noncurrent liabilities | 827 | 382 | |||||||
Total noncurrent liabilities: | 11,104 | 13,156 | 15,300 | 7,623 | 13,758 | 16,980 | |||
Total liabilities: | 21,883 | 18,331 | 21,191 | 20,003 | 21,972 | 26,454 | |||
Equity | |||||||||
Equity, attributable to parent | 22,624 | 21,625 | 19,893 | 19,274 | 26,033 | 25,102 | |||
Common stock | 10,763 | 10,763 | 10,758 | 10,753 | 10,753 | 10,711 | |||
Additional paid in capital | 8,232 | 7,843 | 7,444 | 7,024 | 6,725 | 6,495 | |||
Retained earnings | 3,629 | 3,019 | 1,691 | 1,497 | 8,555 | 7,896 | |||
Equity, attributable to noncontrolling interest | 3,655 | 4,000 | 4,346 | 4,376 | 5,778 | 5,946 | |||
Total equity: | 26,279 | 25,625 | 24,239 | 23,650 | 31,811 | 31,048 | |||
TOTAL LIABILITIES AND EQUITY: | 48,162 | 43,956 | 45,430 | 43,653 | 53,783 | 57,502 |
Income Statement (P&L) ($ in thousands)
9/30/2024 TTM | 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | 12/31/2018 | ||
---|---|---|---|---|---|---|---|---|
Revenues | 21,325 | 19,746 | 17,628 | 17,837 | 20,605 | 19,714 | ||
Cost of revenue | (11,981) | (11,364) | (10,902) | (8,763) | (9,625) | (12,228) | ||
Cost of product and service sold | (7,105) | (6,604) | (7,346) | (2,385) | (2,618) | (2,399) | ||
Other cost of operating revenue | (4,025) | (3,666) | (3,556) | (4,197) | (3,726) | (3,084) | ||
Other undisclosed gross profit | (4,608) | (4,060) | ||||||
Gross profit: | 9,344 | 8,382 | 6,726 | 4,466 | 6,920 | 7,486 | ||
Operating expenses | (7,022) | (5,145) | (4,531) | (4,608) | (4,060) | (3,994) | ||
Other undisclosed operating loss | (2,052) | (806) | (844) | (9,321) | (1,318) | (1,631) | ||
Operating income (loss): | 270 | 2,431 | 1,351 | (9,463) | 1,542 | 1,861 | ||
Nonoperating income (Investment Income, Nonoperating) | 22 | |||||||
Interest and debt expense | (1,112) | (806) | (401) | (1,057) | (1,318) | (1,631) | ||
Other undisclosed income from continuing operations before equity method investments, income taxes | 1,067 | 1,334 | 1,829 | |||||
Income (loss) from continuing operations before equity method investments, income taxes: | (842) | 1,625 | 950 | (9,453) | 1,558 | 2,081 | ||
Other undisclosed income (loss) from continuing operations before income taxes | 1,538 | 893 | (3) | |||||
Income (loss) from continuing operations before income taxes: | 696 | 2,518 | 947 | (9,453) | 1,558 | 2,081 | ||
Income tax expense (benefit) | (431) | (963) | (269) | 1,737 | (128) | (451) | ||
Income (loss) from continuing operations: | 265 | 1,555 | 678 | (7,716) | 1,430 | 1,630 | ||
Income (loss) before gain (loss) on sale of properties: | ✕ | ✕ | ✕ | 678 | (7,716) | 1,430 | 1,630 | |
Net income (loss): | 265 | 1,555 | 678 | (7,716) | 1,430 | 1,630 | ||
Net income (loss) attributable to noncontrolling interest | 345 | (227) | (484) | 658 | (771) | (607) | ||
Net income (loss) available to common stockholders, diluted: | 610 | 1,328 | 194 | (7,058) | 659 | 1,023 |
Comprehensive Income ($ in thousands)
9/30/2024 TTM | 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | 12/31/2018 | ||
---|---|---|---|---|---|---|---|---|
Net income (loss): | 265 | 1,555 | 678 | (7,716) | 1,430 | 1,630 | ||
Comprehensive income (loss): | 265 | 1,555 | 678 | (7,716) | 1,430 | 1,630 | ||
Comprehensive income (loss), net of tax, attributable to noncontrolling interest | 345 | (227) | (484) | 658 | (771) | (607) | ||
Comprehensive income (loss), net of tax, attributable to parent: | 610 | 1,328 | 194 | (7,058) | 659 | 1,023 |
Statements Sources
The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.